MAP2K7 and hepatocellular carcinoma: On the other hand, MEK inhibition in hepatocellular carcinoma decreases MRP1 and MRP3 transporter expression [28], indicating that activation of this pathway is involved in chemoresistance of pancreatic cancer cells [43].